Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


China Delays U.S. Plans To Open Three FDA Foreign Offices

This article was originally published in PharmAsia News

Executive Summary

U.S. plans to open a drug-inspection office in China have hit a snag over diplomatic visas. U.S. FDA plans to establish offices in Beijing, Shanghai and Guangzhou, staffed by 13 employees. The Chinese government has endorsed the idea, but the Ministry of Foreign Affairs has not given its formal approval. The agency wants to set up the offices to give it greater ability to ensure the safety of drug products exported to the United States. Once the China offices are opened, FDA has similar plans for India. (Click here for more - a subscription may be required



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts